Centene Corporation is an American health care provider. Centene primarily acts as a provider of Medicaid and Medicar services and works in these areas with the governments of the relevant states and the United States government. The company serves over 8.6 million Medicaid members and over 400,000 Medicare beneficiaries in the United States.
According to Centene's latest financial reports and stock price the company's current price-to-earnings ratio (TTM) is 13.9866. At the end of 2022 the company had a P/E ratio of 39.4.
The Price/Earnings ratio measures the relationship between a company's stock price and its earnings per share. A low but positive P/E ratio stands for a company that is generating high earnings compared to its current valuation and might be undervalued. A company with a high negative (near 0) P/E ratio stands for a company that is generating heavy losses compared to its current valuation.
Companies with a P/E ratio over 30 or a negative one are generaly seen as "growth stocks" meaning that investors typically expect the company to grow or to become profitable in the future. Companies with a positive P/E ratio bellow 10 are generally seen as "value stocks" meaning that the company is already very profitable and unlikely to strong growth in the future.